Cellular origin and pathophysiology of chronic lymphocytic leukemia

Journal of Experimental Medicine

Volumn 209, Issue 12, 2012, Pages 2183-2198

  Seifert, Marc ^a   Sellmann, Ludger ^a   Bloehdorn, Johannes ^b   Wein, Frederik ^a   Stilgenbauer, Stephan ^b   Dürig, Jan ^a   Küppers, Ralf ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; IMMUNOGLOBULIN; KRUPPEL LIKE FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EBF1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BLOOD; CELL EXPANSION; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; MONOCLONAL B CELL LYMPHOCYTOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPLEEN; TRANSCRIPTOMICS;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD27; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; CLUSTER ANALYSIS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; MICROSCOPY, FLUORESCENCE; MUTATION; OLIGONUCLEOTIDES; PRINCIPAL COMPONENT ANALYSIS; TRANS-ACTIVATORS;

EID: 84872342533     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120833     Document Type: Article

References (79)

1. Allman, D., A. Jain, A. Dent, R.R. Maile, T. Selvaggi, M.R. Kehry, and L.M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood. 87:5257-5268.
2. Andréasson, U., P. Edén, C. Peterson, C.M. Högerkorp, M. Jerkeman, N. Andersen, M. Berglund, C. Sundström, R. Rosenquist, C.A. Borrebaeck, and S. Ek. 2010. Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples. Am. J. Hematol. 85:418-425.
3. Bachl, J., C. Carlson, V. Gray-Schopfer, M. Dessing, and C. Olsson. 2001. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166:5051-5057.
4. Barrena, S., J. Almeida, M. Yunta, A. López, N. Fernández-Mosteirín, M. Giralt, M. Romero, L. Perdiguer, M. Delgado, A. Orfao, and P.A. Lazo. 2005. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia. 19:1376-1383. http://dx.doi.org/10.1038/sj.leu.2403822
5. Berland, R., and H.H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253-300. http://dx.doi.org/10.1146/annurev.immunol.20.100301.064833
6. Brezinschek, H.P., S.J. Foster, R.I. Brezinschek, T. Dörner, R. Domiati-Saad, and P.E. Lipsky. 1997. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J. Clin. Invest. 99:2488-2501. http://dx.doi.org/10.1172/JCI119433
7. Bustelo, X.R., V. Sauzeau, and I.M. Berenjeno. 2007. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 29:356-370. http://dx.doi.org/10.1002/bies.20558
8. Caligaris-Cappio, F. 1996. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood. 87:2615-2620.
9. Caligaris-Cappio, F., M. Gobbi, M. Bofill, and G. Janossy. 1982. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155:623-628. http://dx.doi.org/10.1084/jem.155.2.623
10. Catera, R., G.J. Silverman, K. Hatzi, T. Seiler, S. Didier, L. Zhang, M. Hervé, E. Meffre, D.G. Oscier, H. Vlassara, et al. 2008. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med. 14:665-674. http://dx.doi.org/10 .2119/2008-00102.Catera
11. Chiorazzi, N., and M. Ferrarini. 2011. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 117:1781-1791. http://dx.doi.org/10.1182/blood-2010-07-155663
12. Chu, C.C., R. Catera, K. Hatzi, X.J. Yan, L. Zhang, X.B. Wang, H.M. Fales, S.L. Allen, J.E. Kolitz, K.R. Rai, and N. Chiorazzi. 2008. Chronic lymphocyticleukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood. 112:5122-5129. http://dx.doi.org/10.1182/blood-2008-06-162024
13. Chu, C.C., R. Catera, L. Zhang, S. Didier, B.M. Agagnina, R.N. Damle, M.S. Kaufman, J.E. Kolitz, S.L. Allen, K.R. Rai, and N. Chiorazzi. 2010. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood. 115:3907-3915. http://dx.doi.org/10.1182/blood-2009-09-244251
14. Damle, R.N., T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S.L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, et al. 1999. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840-1847.
15. Damle, R.N., F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, X.J. Yan, C.P. Sison, S.L. Allen, J. Kolitz, P. Schulman, et al. 2002. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 99:4087-4093. http://dx.doi.org/10.1182/blood.V99.11.4087
16. Darzentas, N., A. Hadzidimitriou, F. Murray, K. Hatzi, P. Josefsson, N. Laoutaris, C. Moreno, A. Anagnostopoulos, J. Jurlander, A. Tsaftaris, et al. 2010. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 24:125-132. http://dx.doi.org/10.1038/leu.2009.186
17. DeCoteau, J.F., P.I. Knaus, H. Yankelev, M.D. Reis, R. Lowsky, H.F. Lodish, and M.E. Kadin. 1997. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:5877-5881. http://dx.doi.org/10.1073/pnas.94.11.5877
18. Delerive, P., D. Monté, G. Dubois, F. Trottein, J. Fruchart-Najib, J. Mariani, J.C. Fruchart, and B. Staels. 2001. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep. 2:42-48. http://dx.doi.org/10.1093/embo-reports/kve007
19. Dong, H.Y., A. Shahsafaei, and D.M. Dorfman. 2002. CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells. Leuk. Lymphoma. 43:1855-1858. http://dx.doi.org/10.1080/1042819021000006385
20. Dono, M., V.L. Burgio, M. Colombo, S. Sciacchitano, D. Reverberi, V. Tarantino, G. Cutrona, N. Chiorazzi, and M. Ferrarini. 2007. CD5+ B cells with the features of subepithelial B cells found in human tonsils. Eur. J. Immunol. 37:2138-2147. http://dx.doi.org/10.1002/eji.200636887
21. Dorshkind, K., and E. Montecino-Rodriguez. 2007. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7:213-219. http://dx.doi.org/10.1038/nri2019
22. Enjuanes, A., Y. Benavente, F. Bosch, I. Martín-Guerrero, D. Colomer, S. Pérez-Alvarez, O. Reina, M.T. Ardanaz, P. Jares, A. García-Orad, et al. 2008. Genetic variants in apoptosis and immunoregulationrelated genes are associated with risk of chronic lymphocytic leukemia. Cancer Res. 68:10178-10186. http://dx.doi.org/10.1158/0008-5472. CAN-08-2221
23. Fischer, M., U. Klein, and R. Küppers. 1997. Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation. J. Clin. Invest. 100:1667-1676. http://dx.doi.org/10.1172/JCI119691
24. Forconi, F., K.N. Potter, I. Wheatley, N. Darzentas, E. Sozzi, K. Stamatopoulos, C.I. Mockridge, G. Packham, and F.K. Stevenson. 2010. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood. 115:71-77. http://dx.doi .org/10.1182/blood-2009-06-225813
25. Fukita, Y., H. Jacobs, and K. Rajewsky. 1998. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 9:105-114. http://dx.doi.org/10.1016/S1074-7613(00)80592-0
26. Griffin, D.O., N.E. Holodick, and T.L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208:67-80. http://dx.doi.org/10.1084/jem.20101499
27. Gutierrez, A. Jr., R.C. Tschumper, X. Wu, T.D. Shanafelt, J. Eckel-Passow, P.M. Huddleston III, S.L. Slager, N.E. Kay, and D.F. Jelinek. 2010. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 116:2975-2983. http://dx.doi.org/10.1182/blood-2010-02-269878
28. Ha, Y.J., Y.C. Mun, C.M. Seong, and J.R. Lee. 2008. Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogenactivated protein kinase activation in human cord blood B cells. J. Leukoc. Biol. 84:1557-1564. http://dx.doi.org/10.1189/jlb.0706457
29. Haaland, R.E., W. Yu, and A.P. Rice. 2005. Identification of LKLFregulated genes in quiescent CD4+ T lymphocytes. Mol. Immunol. 42:627-641. http://dx.doi.org/10.1016/j.molimm.2004.09.012
30. Hamblin, T.J., Z. Davis, A. Gardiner, D.G. Oscier, and F.K. Stevenson. 1999. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1848-1854.
31. Hervé, M., K. Xu, Y.S. Ng, H. Wardemann, E. Albesiano, B.T. Messmer, N. Chiorazzi, and E. Meffre. 2005. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115:1636-1643. http://dx.doi.org/10.1172/JCI24387
32. Huggins, J., T. Pellegrin, R.E. Felgar, C. Wei, M. Brown, B. Zheng, E.C. Milner, S.H. Bernstein, I. Sanz, and M.S. Zand. 2007. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood. 109:1611-1619. http://dx.doi.org/10.1182/blood-2006-03-008441
33. Ishida, D., L. Su, A. Tamura, Y. Katayama, Y. Kawai, S.F. Wang, M. Taniwaki, Y. Hamazaki, M. Hattori, and N. Minato. 2006. Rap1 signal controls B cell receptor repertoire and generation of self-reactive B1a cells. Immunity. 24:417-427. http://dx.doi.org/10.1016/j.immuni.2006.02.007
34. Jantus-Lewintre, E., C. Reinoso Martín, C. García Ballesteros, J. Pendas, C. Benet Campos, J.R. Mayans Ferrer, and J. García-Conde. 2009. BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia. Leuk. Lymphoma. 50:773-780. http://dx.doi.org/10 .1080/10428190902842626
35. Johnson, W.E., C. Li, and A. Rabinovic. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 8:118-127. http://dx.doi.org/10.1093/biostatistics/kxj037
36. Kazemi, T., H. Asgarian-Omran, M. Hojjat-Farsangi, M. Shabani, A. Memarian, R.A. Sharifian, S.M. Razavi, M. Jeddi-Tehrani, H. Rabbani, and F. Shokri. 2008. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int. J. Cancer. 123:2113-2119. http://dx.doi. org/10.1002/ijc.23751
37. Kikushige, Y., F. Ishikawa, T. Miyamoto, T. Shima, S. Urata, G. Yoshimoto, Y. Mori, T. Iino, T. Yamauchi, T. Eto, et al. 2011. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 20:246-259. http://dx.doi.org/10.1016/j.ccr.2011.06.029
38. Klein, U., and R. Dalla-Favera. 2008. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8:22-33. http://dx.doi.org/10.1038/nri2217
39. Klein, U., R. Küppers, and K. Rajewsky. 1997. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood. 89: 1288-1298.
40. Klein, U., K. Rajewsky, and R. Küppers. 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689. http://dx.doi.org/10.1084/jem.188.9.1679
41. Klein, U., Y. Tu, G.A. Stolovitzky, M. Mattioli, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, L. Cro, L. Baldini, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625-1638. http://dx.doi.org/10.1084/jem.194.11.1625
42. Koon, H.B., G.C. Ippolito, A.H. Banham, and P.W. Tucker. 2007. FOXP1:a potential therapeutic target in cancer. Expert Opin. Ther. Targets. 11:955-965. http://dx.doi.org/10.1517/14728222.11.7.955
43. Koraae, P., M.G. Vintar, R. Ajdukoviae, M.M. Kardum Paro, B. Jaksiae, and M. Dominis. 2009. FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients. Appl. Immunohistochem. Mol. Morphol. 17:500-504. http://dx.doi.org/10.1097/PAI.0b013e3181a20307
44. Kruetzmann, S., M.M. Rosado, H. Weber, U. Germing, O. Tournilhac, H.H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197:939-945. http://dx.doi.org/10.1084/jem.20022020
45. Küppers, R. 2004. Molecular single-cell PCR analysis of rearranged immunoglobulin genes as a tool to determine the clonal composition of normal and malignant human B cells. Methods Mol. Biol. 271:225-238.
46. Küppers, R., U. Klein, M.-L. Hansmann, and K. Rajewsky. 1999. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341:1520-1529. http://dx.doi.org/10.1056/NEJM199911113412007
47. Kuraoka, M., T.M. Holl, D. Liao, M. Womble, D.W. Cain, A.E. Reynolds, and G. Kelsoe. 2011. Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc. Natl. Acad. Sci. USA. 108:11560-11565. http://dx.doi.org/10.1073/pnas.1102571108
48. Landgren, O., M. Albitar, W. Ma, F. Abbasi, R.B. Hayes, P. Ghia, G.E. Marti, and N.E. Caporaso. 2009. B-cell clones as early markers for chronic lymphocytic leukemia. N. Engl. J. Med. 360:659-667. http://dx.doi.org/10.1056/NEJMoa0806122
49. Maarof, G., L. Bouchet-Delbos, H. Gary-Gouy, I. Durand-Gasselin, R. Krzysiek, and A. Dalloul. 2010. Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood. 115:1718-1726. http://dx.doi.org/10.1182/blood-2009-05-220251
50. Marie-Cardine, A., F. Divay, I. Dutot, A. Green, A. Perdrix, O. Boyer, N. Contentin, H. Tilly, F. Tron, J.P. Vannier, and S. Jacquot. 2008. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin. Immunol. 127:14-25. http://dx.doi.org/10.1016/j.clim.2007.11.013
51. Marshall, J.L., Y. Zhang, L. Pallan, M.C. Hsu, M. Khan, A.F. Cunningham, I.C. MacLennan, and K.M. Toellner. 2011. Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts. Eur. J. Immunol. 41:3506-3512. http://dx.doi.org/10.1002/eji.201141762
52. Messmer, B.T., E. Albesiano, D.G. Efremov, F. Ghiotto, S.L. Allen, J. Kolitz, R. Foa, R.N. Damle, F. Fais, D. Messmer, et al. 2004. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200:519-525. http://dx.doi.org/10.1084/jem.20040544
53. Meyers, G., Y.S. Ng, J.M. Bannock, A. Lavoie, J.E. Walter, L.D. Notarangelo, S.S. Kilic, G. Aksu, M. Debré, F. Rieux-Laucat, et al. 2011. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA. 108:11554-11559. http://dx.doi.org/10.1073/pnas.1102600108
54. Mockridge, C.I., K.N. Potter, I. Wheatley, L.A. Neville, G. Packham, and F.K. Stevenson. 2007. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 109:4424-4431. http://dx.doi.org/10.1182/blood-2006-11-056648
55. Murray, F., N. Darzentas, A. Hadzidimitriou, G. Tobin, M. Boudjogra, C. Scielzo, N. Laoutaris, K. Karlsson, F. Baran-Marzsak, A. Tsaftaris, et al. 2008. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 111:1524-1533. http://dx.doi.org/10.1182/blood-2007-07-099564
56. Muzio, M., B. Apollonio, C. Scielzo, M. Frenquelli, I. Vandoni, V. Boussiotis, F. Caligaris-Cappio, and P. Ghia. 2008. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 112:188-195. http://dx.doi.org/10.1182/blood-2007-09-111344
57. Nahar, R., P. Ramezani-Rad, M. Mossner, C. Duy, L. Cerchietti, H. Geng, S. Dovat, H. Jumaa, B.H. Ye, A. Melnick, and M. Müschen. 2011. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood. 118:4174-4178. http://dx.doi.org/10.1182/blood-2011-01-331181
58. Pasqualucci, L., A. Migliazza, N. Fracchiolla, C. William, A. Neri, L. Baldini, R.S.K. Chaganti, U. Klein, R. Küppers, K. Rajewsky, and R. Dalla-Favera. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA. 95:11816-11821. http://dx.doi.org/10.1073/pnas.95.20.11816
59. Pasqualucci, L., A. Neri, L. Baldini, R. Dalla-Favera, and A. Migliazza. 2000. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 60:5644-5648.
60. Paterson, J.C., S. Tedoldi, A. Craxton, M. Jones, M.L. Hansmann, G. Collins, H. Roberton, Y. Natkunam, S. Pileri, E. Campo, et al. 2006. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica. 91:772-780.
61. Rassenti, L.Z., S. Jain, M.J. Keating, W.G. Wierda, M.R. Grever, J.C. Byrd, N.E. Kay, J.R. Brown, J.G. Gribben, D.S. Neuberg, et al. 2008. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood. 112:1923-1930. http://dx.doi.org/10.1182/blood-2007-05-092882
62. Rosenwald, A., A.A. Alizadeh, G. Widhopf, R. Simon, R.E. Davis, X. Yu, L. Yang, O.K. Pickeral, L.Z. Rassenti, J. Powell, et al. 2001. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 194:1639-1647. http://dx.doi.org/10.1084/jem.194.11.1639
63. Sainz-Perez, A., H. Gary-Gouy, A. Portier, F. Davi, H. Merle-Beral, P. Galanaud, and A. Dalloul. 2006. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia. 20:498-504. http://dx.doi.org/10.1038/sj.leu.2404073
64. Schultze, J., L.M. Nadler, and J.G. Gribben. 1996. B7-mediated costimulation and the immune response. Blood Rev. 10:111-127. http://dx.doi.org/10.1016/S0268-960X(96)90040-5
65. Seifert, M., and R. Küppers. 2009. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J. Exp. Med. 206:2659-2669. http://dx.doi.org/10.1084/jem.20091087
66. Sims, G.P., R. Ettinger, Y. Shirota, C.H. Yarboro, G.G. Illei, and P.E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood. 105:4390-4398. http://dx.doi.org/10.1182/blood-2004-11-4284
67. Sitte, S., J. Gläsner, J. Jellusova, F. Weisel, M. Panattoni, R. Pardi, and A. Gessner. 2012. JAB1 is essential for B cell development and germinal center formation and inversely regulates Fas ligand and Bcl6 expression. J. Immunol. 188:2677-2686. http://dx.doi.org/10.4049/jimmunol.1101455
68. Sohn, H.W., P.D. Krueger, R.S. Davis, and S.K. Pierce. 2011. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood. 118:6332-6341. http://dx.doi.org/10.1182/blood-2011-05-353102
69. Stamatopoulos, K., C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al. 2007. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 109:259-270. http://dx.doi.org/10.1182/blood-2006-03-012948
70. Subramanian, A., P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov. 2005. Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102
71. Tandon, B., L. Peterson, J. Gao, B. Nelson, S. Ma, S. Rosen, and Y.H. Chen. 2011. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod. Pathol. 24:1433-1443. http://dx.doi.org/10.1038/modpathol.2011.103
72. van Oers, M.H., S.T. Pals, L.M. Evers, C.E. van der Schoot, G. Koopman, J.M. Bonfrer, R.Q. Hintzen, A.E. von dem Borne, and R.A. van Lier. 1993. Expression and release of CD27 in human B-cell malignancies. Blood. 82:3430-3436.
73. Weill, J.C., S. Weller, and C.A. Reynaud. 2009. Human marginal zone B cells. Annu. Rev. Immunol. 27:267-285. http://dx.doi.org/10.1146/annurev.immunol.021908.132607
74. Weller, S., M.C. Braun, B.K. Tan, A. Rosenwald, C. Cordier, M.E. Conley, A. Plebani, D.S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 104:3647-3654. http://dx.doi.org/10.1182/blood-2004-01-0346
75. Wolowiec, D., L. Ciszak, A. Kosmaczewska, D. Bocko, R. Teodorowska, I. Frydecka, and K. Kuliczkowski. 2001. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica. 86:1296-1304.
76. Xie, L., A. Ushmorov, F. Leithäuser, H. Guan, C. Steidl, J. Färbinger, C. Pelzer, M.J. Vogel, H.J. Maier, R.D. Gascoyne, et al. 2012. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood. 119:3503-3511. http://dx.doi.org/10.1182/blood-2011-09-381905
77. Yang, S.Y., S.D. Fugmann, and D.G. Schatz. 2006. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J. Exp. Med. 203:2919-2928. http://dx.doi.org/10.1084/jem.20061835
78. Ye, B.H., F. Lista, F. Lo Coco, D.M. Knowles, K. Offit, R.S. Chaganti, and R. Dalla-Favera. 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 262:747-750. http://dx.doi.org/10.1126/science.8235596
79. Zenz, T., D. Mertens, R. Küppers, H. Döhner, and S. Stilgenbauer. 2010. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer. 10:37-50.